SIOUX FALLS, S.D., May 12, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ:SABS), announced today its participation at the H.C. Wainwright Global Investment Conference, which takes place May 23-26, 2022. As part of the conference, the company’s management team will participate in a live Fireside Chat on Wednesday, May 25, 2022 at 9:00 am EDT / 8:00 am CDT.
Read more at globenewswire.comSAB Biotherapeutics to Present at 2022 H.C. Wainwright Global Investment Conference
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here